Ubs Group Ag Sonoma Pharmaceuticals, Inc. Call Options Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SNOA
# of Institutions
11Shares Held
326KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il195KShares$513,2620.0% of portfolio
-
Jane Street Group, LLC New York, NY45.3KShares$119,1250.0% of portfolio
-
Xtx Topco LTD London, X019.8KShares$52,1630.0% of portfolio
-
Two Sigma Securities, LLC New York, NY15.3KShares$40,3040.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY8.27KShares$21,7440.0% of portfolio
About Sonoma Pharmaceuticals, Inc.
- Ticker SNOA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,100,940
- Market Cap $8.16M
- Description
- Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...